<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03668184</url>
  </required_header>
  <id_info>
    <org_study_id>35RC17_3078_PREROVE</org_study_id>
    <nct_id>NCT03668184</nct_id>
  </id_info>
  <brief_title>What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE</brief_title>
  <acronym>PREROVE</acronym>
  <official_title>What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main goal is to determine which risk factors develop preeclampsia in this specific group
      of oocyte recipients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2018</start_date>
  <completion_date type="Anticipated">October 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>occurrence of pre-eclampsia</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">157</enrollment>
  <condition>Pregnancy</condition>
  <condition>Oocyte Donation</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>preeclampsia</intervention_name>
    <description>occurrence of pre-eclampsia</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a pregnancy of more than 22 weeks of amenorrhea resulting from an oocyte
        donation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All major patients with a pregnancy of more than 22 weeks of amenorrhea resulting from
             an oocyte donation in one of the study centers, having given birth between January
             2010 and April 2017 and not opposed to participation in the study.

        Exclusion Criteria:

          -  all pregnancies resulting from an oocyte donation abroad, persons of legal age subject
             to legal protection (safeguard of justice, guardianship, tutorship) and persons
             deprived of their liberty.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Solène DUROS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristell COAT</last_name>
    <phone>299282555</phone>
    <phone_ext>33</phone_ext>
    <email>kristell.coat@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Direction de la Recherche et de l'Innovation</last_name>
    <phone>299282555</phone>
    <phone_ext>33</phone_ext>
    <email>drc@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Solène Duros, MD</last_name>
    </contact>
    <investigator>
      <last_name>Solène DUROS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique de la sagesse</name>
      <address>
        <city>Rennes</city>
        <zip>35043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédérique Jaffré, MD</last_name>
    </contact>
    <investigator>
      <last_name>Frederic Jaffré, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 6, 2018</study_first_submitted>
  <study_first_submitted_qc>September 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 12, 2018</study_first_posted>
  <last_update_submitted>December 17, 2018</last_update_submitted>
  <last_update_submitted_qc>December 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

